We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BLACR

Price
-
Stock movement up
+0.05 (25.00%)
Company name
Bellevue Life Sciences Acquisition Corp. Rights
Exchange
(NASDAQ
,
Currency
USD
)
Market cap
-
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
27.78%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-09-12

DIVIDENDS

BLACR does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
BLACRS&P500
Current price drop from All-time high-14.81%-0.01%
Highest price drop-62.96%-56.47%
Date of highest drop1 Jul 20249 Mar 2009
Avg drop from high-35.12%-10.99%
Avg time to new high16 days12 days
Max time to new high196 days1805 days
COMPANY DETAILS
BLACR (Bellevue Life Sciences Acquisition Corp. Rights) company logo
Marketcap
-
Marketcap category
Small-cap
Description
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Employees
0
Website
Investor relations
-
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner